GLOBAL IMMUNE TECHNOLOGIES INC. — Net Income by Fiscal Year
15 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ce679fe9-2424-4e8b-9746-1c02fe6041ec/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2013 | $-3.2M | 1999-04-01 – 2013-09-30 | evidence 0001185185-13-002543 |
| FY 2012 | $-363.1k | 2012-04-01 – 2013-03-31 | evidence 0001185185-13-002543 |
| FY 2011 | $-65.1k | 2011-04-01 – 2012-03-31 | evidence 0001144204-12-063633 |
| FY 2010 | $-172.4k | 2010-04-01 – 2011-03-31 | evidence 0001144204-12-063627 |
| FY 2009 | $-61.0k | 2009-04-01 – 2010-03-31 | evidence 0001144204-12-063627 |
| FY 2008 | $-53.4k | 2008-04-01 – 2009-03-31 | evidence 0001144204-12-063627 |
| FY 2007 | $-134.3k | 2007-04-01 – 2008-03-31 | evidence 0001144204-12-063627 |
| FY 2006 | $-73.8k | 2006-04-01 – 2007-03-31 | evidence 0001144204-12-063627 |
| FY 2005 | $-95.0k | 2005-04-01 – 2006-03-31 | evidence 0001144204-12-063627 |
| FY 2004 | $-140.6k | 2004-04-01 – 2005-03-31 | evidence 0001144204-12-063627 |
| FY 2003 | $-106.8k | 2003-04-01 – 2004-03-31 | evidence 0001144204-12-063627 |
| FY 2002 | $-79.1k | 2002-04-01 – 2003-03-31 | evidence 0001144204-12-063627 |
| FY 2001 | $-613.4k | 2001-04-01 – 2002-03-31 | evidence 0001144204-12-063627 |
| FY 2000 | $-253.1k | 2000-04-01 – 2001-03-31 | evidence 0001144204-12-063627 |
| FY 1999 | $-563.5k | 1999-04-01 – 2000-03-31 | evidence 0001144204-12-063627 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
GLOBAL IMMUNE TECHNOLOGIES INC. — all facts · Operating Income